"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 3 | 4 | 7 |
| 1997 | 1 | 2 | 3 |
| 1998 | 3 | 4 | 7 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 2 | 3 |
| 2001 | 1 | 2 | 3 |
| 2002 | 3 | 2 | 5 |
| 2003 | 3 | 1 | 4 |
| 2004 | 6 | 3 | 9 |
| 2005 | 4 | 3 | 7 |
| 2006 | 8 | 3 | 11 |
| 2007 | 12 | 5 | 17 |
| 2008 | 6 | 2 | 8 |
| 2009 | 8 | 7 | 15 |
| 2010 | 4 | 6 | 10 |
| 2011 | 6 | 5 | 11 |
| 2012 | 10 | 1 | 11 |
| 2013 | 8 | 14 | 22 |
| 2014 | 11 | 10 | 21 |
| 2015 | 9 | 6 | 15 |
| 2016 | 9 | 14 | 23 |
| 2017 | 13 | 6 | 19 |
| 2018 | 18 | 6 | 24 |
| 2019 | 13 | 4 | 17 |
| 2020 | 13 | 10 | 23 |
| 2021 | 8 | 17 | 25 |
| 2022 | 1 | 13 | 14 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
A proteolytically activated antimicrobial toxin encoded on a mobile plasmid of Bacteroidales induces a protective response. Nat Commun. 2022 07 23; 13(1):4258.
-
Making sense of drug-efflux transporters in the physiological environment. Curr Opin Microbiol. 2022 10; 69:102179.
-
Impact of Ceftazidime Use on Susceptibility Patterns in a Neonatal Intensive Care Unit: A 7.5-year Evaluation. J Pediatric Infect Dis Soc. 2022 07 21; 11(7):349-350.
-
Evaluation of pharmacist time dedicated to vancomycin dosing in adult patients using a 24-hour AUC nomogram or trough monitoring approach: A time motion study. Am J Health Syst Pharm. 2022 07 08; 79(14):1173-1179.
-
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term: a pilot randomized controlled trial. Am J Obstet Gynecol MFM. 2022 09; 4(5):100681.
-
Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia. Intensive Care Med. 2022 07; 48(7):963-964.
-
Property space mapping of Pseudomonas aeruginosa permeability to small molecules. Sci Rep. 2022 05 17; 12(1):8220.
-
Evaluation of Ceftazidime Use in the Neonatal Intensive Care Unit and Association With Cephalosporin-Resistant Gram-Negative Bacteria. Ann Pharmacother. 2022 Dec; 56(12):1325-1332.
-
Methicillin-resistant Staphylococcus aureus enterocolitis in a 16-month-old boy: a case report. J Med Case Rep. 2022 Apr 17; 16(1):155.
-
Bacterial overgrowth assessment and treatment among pediatric intestinal rehabilitation and nutrition support providers: An international survey of clinical practice patterns. JPEN J Parenter Enteral Nutr. 2022 Nov; 46(8):1914-1922.